| Ytd | 76.49% | |
| 1y | 96.87% |
| Open | 115.03 | Prev Close | 115.05 | Low | 115.05 | High | 115.05 | Mkt Cap | 6.73B |
| Vol | 13.19M | Avg Vol | 1.45M | EPS | -4.07 | P/E | N/A | Forward P/E | -66.43 |
| Beta | 0.25 | Short Ratio | 1.56 | Inst. Own | 90.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 112.62 | 200-d Avg | 84.15 | 1yr Est | 112.20 |
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the succe
Here is how Arcellx, Inc. (ACLX) and Astellas Pharma Inc. (ALPMY) have performed compared to their s
Arcellx, Inc. (NASDAQ: ACLX - Get Free Report) has been given an average rating of "Hold" by the nin
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that all
Gilead shares dip after $3.15 billion Tubulis deal adds ADC asset, as multiple acquisitions reshape
Banque Pictet and Cie SA bought a new stake in shares of Arcellx, Inc. (NASDAQ: ACLX) in the fourth
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today extended the expira
Gilead to acquire Ouro Medicines for $1.675 billion, explores Galapagos collaboration, outlines cost
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is inves
Momentum warning for health care sector stocks: RSI indicator shows overbought assets. Arcellx (ACLX
Cormorant Asset Management sold 775,000 Arcellx shares in the fourth quarter. The fund's quarter-end
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Bamco Inc. NY lifted its holdings in Arcellx, Inc. (NASDAQ: ACLX) by 6.2% during the undefined quart
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
Gilead plans a $7.8B Arcellx acquisition as cell therapy sales decline, seeking full control of anit
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde a
Arcellx, Inc. (NASDAQ: ACLX - Get Free Report) has earned an average recommendation of "Hold" from t
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
As of March 4, 2026, two stocks in the health care sector could be flashing a real warning to invest
2 stocks in healthcare sector flashing warning to investors who value momentum. RSI is an indicator
Eli Lilly and Company's shares rose during the quarter as Zepbound's obesity launch continued to gai
ACLX share prices have soared nearly 75% in 2026 due to the recent announcement that Arcellx will be
Arcellx shares rose slightly after Gilead Sciences agreed to acquire the company for $7.8 billion, o
Gilead Sciences to acquire Arcellx for $7.8B, gaining full control of promising CAR T-cell therapy f
FDA lifts REMS for approved CAR-T therapies, easing hospital restrictions and signaling broader futu
Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session follow
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that i
U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Thursday. Here are som
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the co
Upgrades
Upgrades
Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Th